NCT06564805View on ClinicalTrials.gov

Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

December 31, 2025

Conditions
Alopecia Areata
Interventions
DRUG

Candida Albicans Antigen Injection

subcutaneous administration of Candida albicans antigen

Trial Locations (1)

64460

RECRUITING

"Hospital Universitario Dr. José Eleuterio González", Monterrey

All Listed Sponsors
lead

Universidad Autonoma de Nuevo Leon

OTHER